Bipolar Androgen Therapy: A Paradoxical Approach for the Treatment of Castration-resistant Prostate Cancer

Research output: Contribution to journalEditorialpeer-review

Abstract

Bipolar androgen therapy (BAT) is a paradoxical treatment for castrate-resistant prostate cancer whereby testosterone levels are rapidly alternated between supraphysiologic and near-castrate concentrations. Initial studies demonstrated that BAT is safe and produces clinical responses. A trial comparing enzalutamide against BAT is ongoing.

Original languageEnglish (US)
Pages (from-to)323-325
Number of pages3
JournalEuropean Urology
Volume72
Issue number3
DOIs
StatePublished - Sep 2017

ASJC Scopus subject areas

  • Urology

Fingerprint

Dive into the research topics of 'Bipolar Androgen Therapy: A Paradoxical Approach for the Treatment of Castration-resistant Prostate Cancer'. Together they form a unique fingerprint.

Cite this